Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michio Imawari

Showing results (31-40 of 89) with videos related to

Pageof 9
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|December 26, 2008
Role of TNF-alpha produced by nonantigen-specific cells in a fulminant hepatitis mouse modelHiroyasu Ito, Kazuki Ando, Tetsuya Ishikawa, et al.
Clinical Journal of Gastroenterology|July 21, 2015
Two cases of tuberculous peritonitis with liver cirrhosis complicated by refractory ascitesYuu Shimozuma, Takayoshi Ito, Shigeaki Ishii, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 25, 2020
Lusutrombopag Is Safe and Efficacious for Treatment of Thrombocytopenia in Patients With and Without Hepatocellular CarcinomaNaim Alkhouri, Michio Imawari, Namiki Izumi, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|September 26, 2006
Identification of novel hepatitis C virus-specific cytotoxic T lymphocyte epiotpe in NS3 regionKeiichi Ito, Katsuya Shiraki, Kiyomi Funatsuki, et al.
Frontiers in Bioscience (Landmark Edition)|January 4, 2011
TS gene tandem repeats in esophageal cancer patients receiving chemoradiotherapyKazuhiro Kaneko, Maho Nagai, Yoshitaka Murakami, et al.
Journal of Biomedicine & Biotechnology|May 29, 2010
Immune response of cytotoxic T lymphocytes and possibility of vaccine development for hepatitis C virus infectionKazumasa Hiroishi, Junichi Eguchi, Shigeaki Ishii, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|April 24, 2013
Clinical efficacy of combination therapy with ME3738 and pegylated interferon-alpha-2a in patients with hepatitis C virus genotype 1Toshiji Saibara, Nobuyuki Enomoto, Shuichi Kaneko, et al.
Asia Pacific Journal of Clinical Nutrition|January 4, 2017
Relationship of aging and nutritional status to innate immunity in tube-fed bedridden patientsYoshiaki Takeuchi, Tomoe Tashiro, Takuya Yamamura, et al.
Virology|November 18, 2005
Translational enhancement of HCV RNA genotype 1b by 3'-untranslated and envelope 2 protein-coding sequencesKenichi Morikawa, Takayoshi Ito, Hisako Nozawa, et al.
Hepatology (Baltimore, Md.)|April 11, 2012
25-Hydroxyvitamin D3 suppresses hepatitis C virus productionTakuya Matsumura, Takanobu Kato, Nao Sugiyama, et al.
Pageof 9

Showing results (31-40 of 89) with videos related to

Sort By:
Pageof 9
Journal of Immunology (Baltimore, Md. : 1950)|December 26, 2008
Role of TNF-alpha produced by nonantigen-specific cells in a fulminant hepatitis mouse modelHiroyasu Ito, Kazuki Ando, Tetsuya Ishikawa, et al.
Clinical Journal of Gastroenterology|July 21, 2015
Two cases of tuberculous peritonitis with liver cirrhosis complicated by refractory ascitesYuu Shimozuma, Takayoshi Ito, Shigeaki Ishii, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 25, 2020
Lusutrombopag Is Safe and Efficacious for Treatment of Thrombocytopenia in Patients With and Without Hepatocellular CarcinomaNaim Alkhouri, Michio Imawari, Namiki Izumi, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|September 26, 2006
Identification of novel hepatitis C virus-specific cytotoxic T lymphocyte epiotpe in NS3 regionKeiichi Ito, Katsuya Shiraki, Kiyomi Funatsuki, et al.
Frontiers in Bioscience (Landmark Edition)|January 4, 2011
TS gene tandem repeats in esophageal cancer patients receiving chemoradiotherapyKazuhiro Kaneko, Maho Nagai, Yoshitaka Murakami, et al.
Journal of Biomedicine & Biotechnology|May 29, 2010
Immune response of cytotoxic T lymphocytes and possibility of vaccine development for hepatitis C virus infectionKazumasa Hiroishi, Junichi Eguchi, Shigeaki Ishii, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|April 24, 2013
Clinical efficacy of combination therapy with ME3738 and pegylated interferon-alpha-2a in patients with hepatitis C virus genotype 1Toshiji Saibara, Nobuyuki Enomoto, Shuichi Kaneko, et al.
Asia Pacific Journal of Clinical Nutrition|January 4, 2017
Relationship of aging and nutritional status to innate immunity in tube-fed bedridden patientsYoshiaki Takeuchi, Tomoe Tashiro, Takuya Yamamura, et al.
Virology|November 18, 2005
Translational enhancement of HCV RNA genotype 1b by 3'-untranslated and envelope 2 protein-coding sequencesKenichi Morikawa, Takayoshi Ito, Hisako Nozawa, et al.
Hepatology (Baltimore, Md.)|April 11, 2012
25-Hydroxyvitamin D3 suppresses hepatitis C virus productionTakuya Matsumura, Takanobu Kato, Nao Sugiyama, et al.
Pageof 9